Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of AMC Entertainment Holdings Inc (NYSEMKT: AMC) violated securities laws in connection with certain financial statements.
The investigation seeks to discover if possible claims on behalf of purchasers of the securities of AMC Entertainment Holdings Inc (NYSEMKT: AMC) concerning whether a series of statements by AMC Entertainment Holdings Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On June 1, 2015, the Company announced in an Securities and Exchange Commission (SEC) filing that, "[o]n May 28, 2015, AMC Entertainment Inc. (the "Company"), a wholly owned subsidiary of AMC Entertainment Holdings, Inc., received a Civil Investigative Demand ("CID") from the Antitrust Division of the United States Department of Justice in connection with an investigation under Sections 1 and 2 of the Sherman Antitrust Act. On May 29, 2015, the Company also received a CID from the Antitrust Section of the Office of Attorney General of the State of Ohio regarding a similar inquiry under Ohio's antitrust laws. The CIDs request the production of documents and answers to interrogatories concerning potentially anticompetitive conduct, including film clearances and participation in certain joint ventures."
Following the release of this news, shares of AMC dropped $1.46 per share, to 27.45, or more than 5.05%, on June 1, 2015.
Based in Leawood, KS and founded in 1920, AMC Entertainment Holdings Inc operates as a theatrical exhibition company in the U.S. and internationally.
If you purchased shares of AMC Entertainment Holdings Inc (NYSEMKT: AMC) on or before June 1, 2015, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185
